Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the cell transfection market?
The cell transfection market has seen strong growth, expected to rise from $1.29 billion in 2024 to $1.42 billion in 2025, with a CAGR of 9.4%. Growth drivers include increased CRISPR and gene editing studies, rising funding from government and non-government organizations, a growing number of clinical trials using transfected cells, expansion of molecular biology research, and the adoption of high-throughput screening techniques.
What will be the cell transfection market size in the future?
The cell transfection market is anticipated to grow steadily, reaching $2 billion by 2029 at a CAGR of 9.0%. Growth is driven by the rising demand for gene therapy, increasing prevalence of chronic diseases, expansion of biopharmaceutical manufacturing, advances in proteomics and genomics, and growing applications of RNA-based therapeutics. Key trends include higher investments in biotech and pharmaceutical R&D, advancements in transfection technologies, adoption of personalized medicine, transfection applications in cancer research, and development of novel transfection reagents and kits.
Get your cell transfection market report here!
https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report
What main drivers are fueling expansion in the cell transfection market?
The rising number of infectious disease cases is expected to propel the cell transfection market. Inadequate public health infrastructure, vaccine hesitancy, and misinformation contribute to the spread of infectious diseases. Cell transfection is vital in studying infections and developing treatments by enabling gene insertion into cells. For instance, a September 2023 report by the Australian Bureau of Statistics stated that the influenza and pneumonia-associated death rate increased from 31.5 per 100,000 in 2021 to 42.6 per 100,000 in 2022. This growing burden of infectious diseases is anticipated to drive the cell transfection market.
What key areas define the segmentation of the global cell transfection market?
The cell transfectionmarket covered in this report is segmented –
1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods
2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users
Subsegments:
1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation
2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection
3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods
4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction
5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp
Who are the dominant players expanding their reach in the cell transfection market?
Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.
How are evolving market trends shaping cell transfection Strategies?
Leading businesses in the cell transfection sector are incorporating innovations into their transfection systems to provide a more accurate level of control over gene expression. Cell transfection essentially involves introducing foreign nucleic acids into cells to study gene functions, create proteins, and modify gene expression. For example, in July 2024, STEMCELL Technologies, a renowned biotechnology firm based in Canada, presented the Cellpore transfection system. This unique tool aims to boost cell engineering research. The system utilises cutting-edge microfluidic technology to streamline the introduction of assorted macromolecules into cells. This overcomes the challenges prevalent in conventional transfection approaches. The system can transfect around 10 million cells per second, making it apt for heavy-duty applications. It is versatile, compatible with a range of cellular types, including T cells and hematopoietic stem cells. Furthermore, it can administer varied cargoes such as small molecules, RNA, proteins, and antibodies.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19361
Which regions are emerging as leaders in the cell transfection market?
North America was the largest region in the cell transfection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cellular or Mobile Telephone Services Global Market Report 2024
Cell Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Cellular Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
